BI
IMDZ

BVF Inc’s Immune Design Corp. IMDZ Stock Holding History

BVF Inc’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-5,185,383
Closed -$6.74M – 59
2018
Q4 		$6.74M Buy
5,185,383
+527,030
+11% +$916K 0.88% 35
2018
Q3 		$16.1M Buy
4,658,353
+500,000
+12% +$1.88M 1.41% 24
2018
Q2 		$18.9M Buy
4,158,353
+52,153
+1% +$208K 1.85% 21
2018
Q1 		$13.6M Buy
4,106,200
+2,636,400
+179% +$9.33M 1.37% 21
2017
Q4 		$5.73M Buy
+1,469,800
New +$8M 0.69% 32
2017
Q2 		– Sell
-1,233,976
Closed -$8.39M – 35
2017
Q1 		$8.39M Sell
1,233,976
-86,188
-7% -$498K 1.43% 20
2016
Q4 		$7.26M Buy
1,320,164
+120,164
+10% +$849K 1.46% 19
2016
Q3 		$9.1M Buy
+1,200,000
New +$8.77M 1.71% 17

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

BVF Inc's IMDZ Position: Q1 2019 in Review

BVF Inc sold out of Immune Design Corp. (IMDZ) in Q1 2019, closing a stake of 5,185,383 shares — an estimated $6.74M sold.

BVF Inc first reported a position in IMDZ in Q3 2016 and held it in 8 quarters. The position peaked at $18.9M in Q2 2018. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • BVF Inc reported no remaining Immune Design Corp. position as of Q1 2019 after selling out during the quarter.
  • BVF Inc sold 5,185,383 Immune Design Corp. shares in Q1 2019, an estimated $6.74M.
  • BVF Inc first reported a position in Immune Design Corp. in Q3 2016 and held it in 8 quarters.
  • BVF Inc's Immune Design Corp. position peaked at $18.9M in Q2 2018.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on BVF Inc's 13F filing for Q1 2019, filed 15 May 2019.